Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Christopher Uchiyama

Neurological Surgery La Jolla, CA Medical Doctor

NPI 1386695625 CMS profile 153082

10666 N Torrey Pines Rd, La Jolla, CA 92037

Open in the dashboard

General payments

$12,279

185 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Christopher Uchiyama of La Jolla, CA is reported in the CMS Open Payments database as having received $12,279 across 185 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 72nd percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,281 10
2024 General $134 5
2023 General $208 31
2022 General $693 42
2021 General $1,973 38
2020 General $2,226 24
2019 General $3,764 35

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christopher Uchiyama
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Christopher Uchiyama were reported at $3,281. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Christopher Uchiyama Neurological Surgery median Middle half National median
2019 $3,764 $582 $138–$3,006 $163
2020 $2,226 $294 $76–$2,174 $114
2021 $1,973 $387 $105–$2,432 $132
2022 $693 $542 $139–$2,989 $149
2023 $208 $534 $145–$2,697 $160
2024 $134 $574 $155–$3,046 $164
2025 $3,281 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $6,176 141 payments
  2. Koh Young America, Inc. $2,804 3 payments
  3. Medtronic USA, Inc. $2,513 22 payments
  4. DePuy Synthes Sales Inc. $181 6 payments
  5. Orthofix Medical, Inc. $158 1 payment
  6. Saluda Medical Americas, Inc. $119 1 payment
  7. Microtransponder, Inc. $77 1 payment
  8. Seaspine Orthopedics Corporation $69 1 payment
  9. Medtronic, Inc. $52 3 payments
  10. Ziehm Imaging, Inc. $35 1 payment
  11. Other $95 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,500 3 payments
  2. Food and Beverage $3,894 177 payments
  3. Consulting Fee $2,500 1 payment
  4. Travel and Lodging $1,385 4 payments
Products named General payments · program years 2019–2025
  1. Geniant Cranial $2,804 3 payments
  2. CD HORIZON $2,377 18 payments
  3. PRECISION $2,000 1 payment
  4. WAVEWRITER ALPHA $1,500 1 payment
  5. SPECTRA WAVEWRITER $1,000 1 payment
  6. GENERAL PAIN MANAGEMENT $540 39 payments
  7. General - Pain Management General - Pain Management_NMD $237 20 payments
  8. General - Therapies $185 11 payments
  9. GENERAL - PAIN MANAGEMENT Pain Management $174 24 payments
  10. Shoreline ASC $158 1 payment
  11. Other $1,063 33 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 76 billing codes

Paid by Medicare

$183,167

Medicare's payments for the services billed

Medicare patients

354

Average age 74

Services billed

786

210 women, 144 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 67%
Depression 29%
Osteoporosis 28%
Ischemic heart disease 26%
Chronic kidney disease 23%
Diabetes 18%
Cancer 15%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

185 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record